Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
small decrease » small increased (Expand Search)
test decrease » teer decrease (Expand Search), cost decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
care test » care tests (Expand Search), pre test (Expand Search), care testing (Expand Search)
_ largest » _ large (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
small decrease » small increased (Expand Search)
test decrease » teer decrease (Expand Search), cost decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
care test » care tests (Expand Search), pre test (Expand Search), care testing (Expand Search)
_ largest » _ large (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Why does task performance decrease with burst length?
Published 2025“…See <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013125#pcbi.1013125.s001" target="_blank">S1 Appendix</a>.…”
-
9
-
10
Sleep deprivation increased inflammatory cytokines and decreased corticosterone in the blood.
Published 2025Subjects: -
11
-
12
-
13
-
14
-
15
DataSheet1_Decreasing viscosity and increasing accessible load by replacing classical diluents with a hydrotrope in liquid–liquid extraction.docx
Published 2025“…We show that using hydrotropes as a diluent decreases the viscosity of solutions by more than a factor of ten, even under high load by extracted cations. …”
-
16
Cascade of care by HCV testing model.
Published 2025“…HCVST at CBOs and clinics was more costly than standard testing ($636 vs. $408 and $605 vs. $218). HCVST was still costlier at CBOs but cheaper at clinics compared to standard testing when kit costs decreased to $2 ($417 vs. $218 and $357 vs. $408). …”
-
17
Data and code from: Continental declines in North American small mammal populations
Published 2025Subjects: -
18
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
19
-
20